Biotechnology News

April 3, 2012

MANCHESTER, England--(BUSINESS WIRE)--Intertek announced today the launch of cGMP compliant Cell Based Assay services for biologic therapeutics in its European Centre of Excellence for Biopharmaceuticals at Manchester, UK.

April 3, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has established an affiliate in Hong Kong. At the end of last year, Meda opened its China affiliate based in Beijing. Meda will begin by commercializing two of its well-...

April 3, 2012

BRUSSELS & ATLANTA--(BUSINESS WIRE)--UCB announced today that the U.S. Food and Drug Administration (FDA) approved Neupro® (Rotigotine Transdermal System) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson’s...

April 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Launches HER2Sense™ Discovery Research Imaging Agent to Enable Personalized Medicine Approaches for Breast Cancer Research

April 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today that it has...

April 2, 2012

SEATTLE--(BUSINESS WIRE)--The dates for Life Science Innovation Northwest (LSINW) 2012 have been set for July 11-12, 2012 at the Washington State Convention Center. Chris E. Rivera, President, Washington Biotechnology & Biomedical Association...

April 2, 2012

LEBANON, N.H.--(BUSINESS WIRE)--Adimab raises Series F on good financial terms to support platform expansion.

April 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that its Board of Directors...

April 2, 2012

MADISON, Wis.--(BUSINESS WIRE)--The Small Business Scholarship Program for BIO 2012 is designed to enable Wisconsin bioscience companies (health, agriculture, energy, medical device, etc.) to participate fully in BIO 2012.

April 2, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing cannabis pharmaceutical and over the counter nutraceutical products, is pleased to report it is moving forward with its FDA IND process. We...

April 2, 2012

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fenwal receives FDA clearance for therapeutic plasma exchange on its Amicus separator

April 2, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Ximedica has been recognized as a 2012 Medical Design Excellence Award (MDEA) finalist for development work on the TissuGlu applicator, a new product introduction for Cohera Medical, Inc.

April 2, 2012

NORWALK, Conn. & PHOENIX--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced a unique oncology research partnership. This multi-year agreement involves several partners including the Translational Genomics...

April 2, 2012

GILBERTSVILLE, Pa.--(BUSINESS WIRE)--Rockland Immunochemicals Develops Antibodies involved in Cell Signaling Through a Unique Partnership with the National Cancer Institute’s Center for Cancer Research

April 2, 2012

PHILADELPHIA--(BUSINESS WIRE)--The BRAVE Awards, an international awards program intended to recognize everyday people who serve as caregivers, is now accepting nominations. Developed and implemented by Shire plc, the global specialty...

April 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its first quarter 2012 financial results at 4:00 p.m. ET on Wednesday, April 18th, 2012. In connection with this announcement, Cubist will host a conference...

April 2, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta AB (STO:EKTAB): NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, HONG KONG OR AUSTRALIA At the Extraordinary General Meeting of Shareholders of Elekta AB (publ) held on...

April 2, 2012

NEW YORK--(BUSINESS WIRE)--Needham & Company, LLC will host its 11th Annual Healthcare Conference at the New York Palace Hotel on April 3-4, 2012.

April 2, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that data from the pivotal Phase III study with ZOSTAVAX® (Zoster Vaccine Live) in adults ages 50 to 59 were published...

April 2, 2012

CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation names Wayne Pisano as President, CEO and Board member. Pisano, who is the former CEO of sanofi pasteur, is a global leader in vaccine development, production and sales.

April 2, 2012

LEXINGTON, Mass. & CHICAGO--(BUSINESS WIRE)--RainDance Launches Comprehensive Sequencing Panel for Cancer Mutation Screening and Research

April 2, 2012

NEW YORK & DALLAS--(BUSINESS WIRE)--CTNeT selects Medidata Solutions as strategic partner and will build innovative, streamlined operations with Medidata’s clinical development technology platform.

April 2, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Presents Data at ECCMID from Growing Portfolio of Next-Generation Antibiotic Candidates

April 2, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today announced that Forest Laboratories Holdings Limited (Forest), its wholly owned subsidiary, and Janssen Pharmaceutica NV (Janssen) entered into an agreement under which Forest...

April 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway presented at AACR by Bioscale.

April 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The increased use of targeted therapies will be a key factor driving growth of the colorectal cancer drug market in China.

April 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--AlloCure, Inc., a clinical stage biotechnology company focused on the treatment of kidney disease, today announced the closing of a $25 million Series B venture financing.

April 2, 2012

BOSTON--(BUSINESS WIRE)--Investigative sites worldwide see encouraging signs of financial recovery, according to a new 2012 CenterWatch study benchmarking global investigative site workload, staffing and financial performance

April 2, 2012

LONDON--(BUSINESS WIRE)--PolyTherics and Spirogen to develop antibody drug conjugates (ADCs) that combine site-specific conjugation chemistry with potent cytotoxic drugs to produce novel ADCs for the treatment of cancer.

April 2, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides had its first pre-IND Meeting with US FDA for its influenza drug, NV-INF-1 on March 29.

April 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Chief Medical Officer Mark Monane, M.D., will present an overview of the company and of Corus® CAD, the first...

April 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, announced today an expansion of its previous collaboration with...

April 2, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC) has now published its Annual Report for 2011 in both Swedish and English on its website www....

April 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: According to the Norwegian Securities Trading Act, section 5-11, issuers of listed transferable securities are required to provide Oslo Stock Exchange with an annual statement of information made...

April 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that its lead compound, cabozantinib, will be the subject of nine separate data presentations at the upcoming Annual Meeting of the American Society of...

April 2, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen announced today the appointment of Martin Olin to the position of Chief Financial Officer. Symphogen also said it received the second of three tranches of capital specified in its €100 million 2011...

April 2, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Bicycle Therapeutics, a next generation biotherapeutics company, today announced the appointment of Rolf Günther, MD, PhD as Chief Executive Officer.

April 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced estimated first quarter revenue of approximately $270 million. This number is based on a preliminary estimate and remains subject to review by Illumina’s independent...

April 2, 2012

GENEVA--(BUSINESS WIRE)--Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global...

April 2, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has commenced commercial launch of both Irbesartan and Irbesartan-Hydrochlorothiazide Tablets, the Company’s generic versions of Sanofi Aventis...

April 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical data for saridegib (IPI-926), its novel oral molecule that inhibits Smoothened, a key component of the Hedgehog pathway. Data...

April 1, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid...

April 1, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd (TASE:MZOR), the leader in innovative surgical robots and complementary products for spine surgery, today announced that Florida Hospital Carrollwood, a 120-bed community hospital in Tampa, FL...

March 31, 2012

CAMBRIDGE, Mass. & CHICAGO--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces new protocols and reference libraries for mycobacteria and multicellular fungi to further extend the...

March 31, 2012

CHALFONT ST GILES, England & BURLINGTON, Mass.--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE:GE), and Dyax Corp. (NASDAQ:DYAX) today announced a licensing agreement for the development and commercialization of peptides binding to c-Met...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network for the Rapid Identification of Anaerobes (...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Highlights Innovative Solutions for Enabling Personalized Medicine in Cancer Research at AACR 2012